Osaka, Japan

Tsumoru Miyamoto


 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Kyoto, JP (1995)
  • Osaka, JP (1991 - 1996)
  • Shiga, JP (1995 - 2000)

Company Filing History:


Years Active: 1991-2000

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations by Tsumoru Miyamoto: Pioneering Carbocyclic Sulfonamides

Introduction: Tsumoru Miyamoto is an influential inventor based in Osaka, Japan, with a notable portfolio of 13 patents. His groundbreaking work predominantly focuses on the development of carbocyclic sulfonamides that play a significant role in medicinal chemistry. Miyamoto's inventions have contributed to advancements in treating various medical conditions, particularly those related to the prostaglandin E2 receptor.

Latest Patents: Tsumoru Miyamoto's latest patents include several innovative compounds and processes centered around carbocyclic sulfonamides. Key applications of his recent patents involve:

1. Prostaglandin (PG) E2 antagonist or agonist containing carbocyclic sulfonamides represented by the compound of a specific formula, along with cyclodextrin clathrates and non-toxic salts.

2. A second compound of the formula, also yielding cyclodextrin clathrates and non-toxic salts.

3. A detailed process for preparing the aforementioned compound.

4. An active ingredient that leverages the second compound to function as a PGE2 antagonist or agonist.

These compounds have the potential to be adapted into medicines exhibiting various therapeutic effects including, but not limited to, the inhibition of uterine contractions, analgesic effects, and the modulation of digestive peristalsis.

Career Highlights: Miyamoto currently works at Ono Pharmaceutical Co., Ltd., a leading pharmaceutical company, where he continues to explore innovative pharmaceutical solutions. His career is marked by significant contributions to the field of medicinal chemistry and drug development, establishing him as a key figure in his industry.

Collaborations: Throughout his career, Tsumoru Miyamoto has collaborated with notable colleagues, including Masaaki Toda and Shuichi Ohuchida. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge, ultimately leading to advancements in drug development.

Conclusion: Tsumoru Miyamoto stands out as a prominent inventor in the realm of medicinal chemistry, with a focus on carbocyclic sulfonamides. His innovative contributions, particularly through his latest patents, demonstrate a commitment to enhancing therapeutic solutions. As he continues to work alongside esteemed colleagues in the field, Miyamoto's impact on medicine and pharmaceutical development remains significant.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…